Phenobarbital but Not Diazepam Reduces AMPA/kainate Receptor Mediated Currents and Exerts Opposite Actions on Initial Seizures in the Neonatal Rat Hippocampus by Romain Nardou et al.
CELLULAR NEUROSCIENCE
ORIGINAL RESEARCH ARTICLE
published: 28 July 2011
doi: 10.3389/fncel.2011.00016
Phenobarbital but not diazepam reduces AMPA/kainate
receptor mediated currents and exerts opposite actions on
initial seizures in the neonatal rat hippocampus
Romain Nardou1,2,3†, SumiiYamamoto1,2,3†, Asma Bhar1,2,3†, Nail Burnashev1,2,3,Yehezkel Ben-Ari1,2,3* and
Ilgam Khalilov1,2,3
1 INSERM U-901, Marseille, France
2 UMR S901 Aix-Marseille 2, Université de la Méditerranée, Marseille, France
3 Institute for International Medicine, Marseille, France
Edited by:
Enrico Cherubini, International School
for Advanced Studies, Italy
Reviewed by:
Gianmaria Maccaferri, Northwestern
University, USA
Shaoyu Ge, SUNY Stony Brook, USA
*Correspondence:
Yehezkel Ben-Ari, Campus
Scientiﬁque de Luminy, 163 route de
Luminy, 13009 Marseille, France.
e-mail: ben-ari@inmed.univ-mrs.fr
†Romain Nardou, Sumii Yamamoto
and Asma Bhar have contributed
equally to this work.
Diazepam (DZP) and phenobarbital (PB) are extensively used as ﬁrst and second line drugs
to treat acute seizures in neonates and their actions are thought to be mediated by increas-
ing the actions of GABAergic signals. Yet, their efﬁcacy is variable with occasional failure
or even aggravation of recurrent seizures questioning whether other mechanisms are not
involved in their actions. We have now compared the effects of DZP and PB on ictal-
like events (ILEs) in an in vitro model of mirror focus (MF). Using the three-compartment
chamber with the two immature hippocampi and their commissural ﬁbers placed in three
different compartments, kainate was applied to one hippocampus and PB or DZP to the
contralateral one, either after one ILE, or after many recurrent ILEs that produce an epilep-
togenic MF. We report that in contrast to PB, DZP aggravated propagating ILEs from the
start, and did not prevent the formation of MF. PB reduced and DZP increased the net-
work driven giant depolarizing potentials suggesting that PB may exert additional actions
that are not mediated by GABA signaling. In keeping with this, PB but not DZP reduced
ﬁeld potentials recorded in the presence of GABA and NMDA receptor antagonists.These
effects are mediated by a direct action on AMPA/kainate receptors since PB: (i) reduced
AMPA/kainate receptor mediated currents induced by focal applications of glutamate; (ii)
reduced the amplitude and the frequency of AMPA but not NMDA receptor mediated
miniature excitatory postsynaptic currents (EPSCs); (iii) augmented the number of AMPA
receptor mediated EPSCs failures evoked by minimal stimulation. These effects persisted
in MF. Therefore, PB exerts its anticonvulsive actions partly by reducing AMPA/kainate
receptors mediated EPSCs in addition to the pro-GABA effects. We suggest that PB may
have advantage over DZP in the treatment of initial neonatal seizures since the additional
reduction of glutamate receptors mediated signals may reduce the severity of neonatal
seizures.
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INTRODUCTION
Neonatal seizures are inherently different from adult seizures and
canbe refractory to anti epileptic drugs (AEDs). Benzodiazepines –
notably diazepam (DZP) – and phenobarbital (PB) are the AEDs
of ﬁrst choice to treat neonatal seizures (Wheless et al., 2007; Bas-
san et al., 2008). In general, PB is ﬁrst used in neonatal seizures
whereas diazepam or lorazepam are preferred in febrile seizures.
They are thought to reduce seizures by reinforcing the efﬁcacy
Abbreviations: AED, anti epileptic drug; APV, d-2-amino-5-phosphopentanoate;
CNQX, 6-cyano-7-nitroquinoxaline-2,3 dione; DZP, diazepam; GABA, γ-
aminobutyric acid; GDP, giant depolarizing potential; ILE, ictal-like event; IILE,
interictal-like event; KCC2, potassium–chloride co-transporter 2; NKCC1, sodium–
potassium–chloride co-transporter 1; PB, phenobarbital; PTX, picrotoxin; TTX,
tetrodotoxin.
of GABAergic inhibition through a direct action on GABA(A)
receptors mediated currents. However, there are several compli-
cating factors with their use. In many conditions they fail to block
seizures, produce an electro-clinical disconnection of EEG and
clinical signs (Connell et al., 1989; Painter et al., 1999; Boylan
et al., 2002;Yanay et al., 2004; Guillet and Kwon, 2007; Kaindl et al.,
2008) and even aggravate them (Loscher and Honack, 1989; Guer-
rini et al., 1998; Perucca et al., 1998; Painter et al., 1999; Goodkin
et al., 2008; Goodkin and Kapur, 2009). These aggravating actions
are at least partly mediated by a persistent increase of [Cl−]i lead-
ing to more seizures by enhancing the excitatory actions of GABA
that heavily depend on this parameter (also see Cohen et al., 2002;
Khalilov et al., 2003, 2005; Rivera et al., 2004; Glykys et al., 2009;
Dzhala et al., 2010;Nardou et al., 2011). Experimental observations
indicate that PB efﬁciently blocks early seizures but aggravates
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established ones when ﬁrst applied after many recurrent seizures.
This is due to a persistent accumulation of chloride and excita-
tory actions of GABA that will be further enhanced by PB (Glykys
et al., 2009; Dzhala et al., 2010; Nardou et al., 2011). These effects
are mediated by a persistent activation of the chloride importer
NKCC1 and a down regulation and internalization of the chloride
exporter KCC2 (Dzhala et al., 2010; Lee et al., 2010; Nardou et al.,
2011). Clearly, the regulation of [Cl−]i constitutes a major source
of problem to the use of these AEDs and stresses the importance
of the history of seizures prior to treatment in determining the
efﬁcacy of the treatment.
Collectively however, these observations are based on the
assumption that the actions of PB,DZP, and other members of this
family are solelymediated byGABA signaling.Yet, there are several
indications that this may not be the case. Barbiturate anesthet-
ics have been reported to antagonize glutamate evoked currents
in spinal neurons (MacDonald and Barker, 1978a,b, 1982; Mac-
donald and Kelly, 1994) and to reduce recombinant AMPA-type
glutamate receptor channels expressed in cell lines (Jin et al., 2010).
Also, barbiturates are more efﬁcacious than benzodiazepines to
treat various brain disorders including neonatal seizures (Cheng
et al., 2002; Soderpalm, 2002; Carmo and Barr, 2005; Bartha et al.,
2007) raising the possibility that additional non-GABA mediated
signaling may underlie a better efﬁcacy to treat various neona-
tal seizures. These observations stress the importance of both
determining the possible non-GABA mediated actions of these
AEDs and taking into account the differences between acute and
recurrent more chronic seizures in order to determine possible
aggravating deleterious actions.
Here, we compared the actions of PB and DZP on gluta-
mate receptor mediated currents in naïve and “epileptic” imma-
ture hippocampal neurons. In that purpose, we used the triple
chamber preparation that enables to apply to one chamber a
convulsive agent (kainate) and an AED to the other and inter-
rupt the connections after one or more propagated seizures
(Khalilov et al., 1997, 1999, 2003). In this preparation, the con-
tralateral hippocampus becomes epileptic as it generates spon-
taneous seizures when disconnected from the kainate treated
side. This enables to compare the actions of AEDs on naïve and
epileptic mirror foci. Using this preparation, we showed recently
(Nardou et al., 2011) that PB efﬁciently blocks paroxysmal activ-
ity when applied with the initial seizures but aggravates them
when applied late on a newly formed mirror focus (MF). This
is due to an excessive increase of [Cl−]i leading to excitatory
GABA that PB will further exacerbates (Nardou et al., 2011).
We now report that in contrast to PB, DZP aggravates inau-
gurating, and established seizures. These differences are due to
the selective actions of PB that reduces AMPA/kainate recep-
tor mediated signals in addition to its pro-GABA actions. This
dual action of PB on GABA and glutamate excitatory postsy-
naptic currents (EPSCs) provides an obvious important advan-
tage of PB over DZP and may have as such important clinical
implications.
MATERIALS AND METHODS
Experiments were performed on neonatal Wistar rats (postnatal
days P6–P8). All experiments have been carried out in accordance
with the European Communities Council Directive of the 24
November 1986 (86/609/EEC).
TISSUE PREPARATION
Intact hippocampal preparation
The interconnected intact hippocampi were prepared according
to the procedures described previously (Khalilov et al., 1997).
In brief, neonatal rats and mice (P6–P8) were decapitated after
hypothermic anesthesia, the brain rapidly removed to oxygenated
(95% O2/5% CO2) ice-cold artiﬁcial cerebrospinal ﬂuid (ACSF)
containing (in mM): NaCl 126, KCl 3.5, CaCl2 2.0, MgCl2 1.3,
NaHCO3 25, NaH2PO4 1.2, and glucose 11 (pH 7.4). The two
interconnected intact hippocampi were isolated and transferred
into a beaker containing oxygenated ACSF and incubated at least
1 h before use. The hippocampi were placed into a fully submerged
three-compartment chamber and superfused with oxygenated
ACSF (30–32˚C, 10–15ml/min).
Slice preparation
Slices (thickness 450μm) were cut using a Leica VT-1000E
vibratome (Leica Microsystems GmbH, Nussloch, Germany) or a
McIIwain tissue chopper (slices 600μm thick) and kept in oxy-
genated ACSF at room temperature for at least 1 h before use
(Khalilov et al., 2005). Slices from epileptic hippocampi were pre-
pared as described earlier (Nardou et al., 2009). Individual slices
were then transferred to the recording chamber where they were
fully submerged and superfused with oxygenated ACSF (30–32˚C,
2–3ml/min).
ELECTROPHYSIOLOGICAL RECORDINGS AND DATA ANALYSIS
Hippocampal CA3 pyramidal neurons in the slices were visualized
with infrared differential interference contrast microscopy (Nikon
Eclipse FN).
Whole cell recordings were collected using an Axopatch 200B
and MultiClamp 700B ampliﬁers (Axon Instruments, USA). Patch
electrodes were made from borosilicate glass capillaries (G150F-
15; Warner Instrument Corporation, Hamden, CT, USA) using
themodel PP-830 two-stagemicropipette puller (Narishige,Tokyo,
Japan). Patch pipette solution contained (inmM):CsCl 140,CaCl2
1, EGTA 10, HEPES 10, MgATP 2, and GTP 0.4 (pH 7.25), and
an osmolarity of 280mOsm. Patch pipettes had a resistance of
8–10MΩ.
To evoke synaptic responses in pyramidal CA3 neurons, a con-
centric bipolar tungsten electrode (FHC, Bowdoinham,ME,USA)
was placed in stratum lucidum. Single pulseswere deliveredusing a
Master-8pulse generator (A.M.P.I., Jerusalem,Israel) controlledby
a PC, and stimulus intensity was controlled by a constant current
stimulus isolator. AMPA/kainate receptor mediated EPSCs. EPSCs
were evoked in the presence of NMDA and GABA receptor antag-
onists (40μM D-APV, 10μM bicuculline, and 2μM CGP55845)
and minimal afferent stimulation was used to activate one or
few ﬁbers. The minimal EPSCs were associated with occasional
response failures. Their number was usually estimated by visual
discrimination. The means of evoked EPSCs was determined by
excluding the failures and making only means of the successful
evoked responses. To conﬁrm that responses were AMPA/kainate
receptor mediated, an AMPA/kainate receptor antagonist (10 or
20μM CNQX) was used to block responses.
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Cells were identiﬁed by adding biocytin (0.4%) to the pipette
solution for post hoc morphological analysis.
Nucleated patch clamp recordings were performed from CA3
pyramidal neurons in hippocampal slices using fast agonist appli-
cation techniques in the standard external solution. After the
whole cell conﬁguration was made, nucleated (Sather et al.,
1992) patches were pulled from the cell and placed in front of
a piezo-controlled (P 245.70, Physik Instrumente, Waldbronn,
Germany) fast application system with a double-barreled appli-
cation pipette (Colquhoun et al., 1992). Glutamate (1mM)
pulses of 2ms duration were applied every 10 s. Recordings
were made using an EPC-9 ampliﬁer (HEKA Electronics, Lam-
brecht, Germany) under visualization with a Leica microscope.
The resistance of the pipettes was 4–5MΩ. PB (100μM) and
diazepam (2μM) were added to the extracellular solution. Exper-
iments were performed at a holding potential of –60mV. Cur-
rent traces shown are averages of four to eight sweeps. Stim-
ulus delivery and data acquisition was performed using Pulse
software (Heka Elektronik, Lambrecht, Germany). Analyses were
performed using IgorPro software (WaveMetrics, Lake Oswego,
OR, USA).
Extracellular ﬁeld potentials and multi-unit activities (MUAs)
were recorded in the hippocampal slices and in the intact hip-
pocampal preparations in vitro using tungsten wire electrodes
(diameter: 50μm, California Fine Wire, Grover Beach, CA, USA)
and a low-noise multichannel DAM-8A ampliﬁers (WPI, GB; low
ﬁlter: 0.1Hz; high ﬁlter: 3 KHz; ×1000). Electrical stimulations
were performed with a bipolar electrode (10–20V, 40 μs).
The signals were digitized using an analog-to-digital converter
(Digidata 1440A,Axon Instruments,USA). pCLAMP10.1,Clamp-
ﬁt 10.1 (Axon Instruments, USA), MiniAnalysis 6.03 (Synap-
tosoft, Decatur, CA, USA), and Origin 7.5 (Microcal Software,
USA) programs were used for the acquisition and analysis of
the synaptic activities. Sampling interval per signal was 100 μs
(10 kHz). Spikes (single unit activity) in extracellular recordings
were detected by amplitude thresholding using MiniAnalysis 6.03
program. Power spectrum analysis was performed after applying
a Hamming window function. Power was calculated by inte-
grating the root mean square value of the signal in frequency
bands from 1 to 1000Hz. Time–frequency representations of
ictal-like events were obtained using continuous Morlet wavelet
transforms using AutoSignal v1.7 software (SeaSolve Software
Inc.).
FOCAL PUFF APPLICATIONS OF GLUTAMATE AND γ-AMINOBUTYRIC
ACID
A picospritzer (GeneralValve Corporation, Fairﬁeld,NJ,USA) was
used to puff-apply (5–10 psi for 50–100ms) of glutamate orGABA
from a glass pipette at a distance of about 100–150 μm from the
soma, adjusted such that postsynaptic current amplitudes did not
exceed 300 pA.
STATISTICAL ANALYSIS
Group measures are expressed as mean± SEM; error bars also
indicate SEM. The statistical signiﬁcance of differences was
assessed with the Student’s t -test. The level of signiﬁcance was
set at p< 0.05.
PHARMACOLOGICAL AGENTS
Antagonists bicuculline (10μM), 6-cyano-7-nitroquinoxaline-2,3
dione (CNQX, 10μM), d-2-Amino-5-phosphopentanoate (APV,
40μM), tetrodotoxin (TTX, 1μM), picrotoxin (PTX, 100μM),
CGP55845 (CGP, 2μM); AEDs Diazepam (DZP, 2μM) and
(PB, 100μM); and kainate (KA, 400 nM) were directly added
to the perfusion solutions. The drugs used were purchased
from Sigma (DZP, PB, TTX, PTX, CGP, glutamate, and kainic
acid), Tocris (bicuculline, CNQX, APV), and Molecular Probes
(biocytin).
RESULTS
DIAZEPAM AGGRAVATES THE PROPAGATING ICTAL-LIKE EVENTS AND
DOES NOT PREVENT THE FORMATION OF A MIRROR FOCUS BY
REPEATED ILES
We used the triple chamber preparation with the two intact
hippocampi and the commissural connections in three differ-
ent compartments (Khalilov et al., 1997, 1999). This enables to
apply different agents on each compartment without diffusion
and interference with the others (Khalilov et al., 2003). In a ﬁrst
series of experiments, we applied kainate (KA, 400 nM) to one
hippocampus (referred to as the ipsilateral hippocampus, ipsi-)
and recorded the activity from both the ipsi- and the contralat-
eral (contra-) hippocampus that did not receive the convulsive
agent (Figure 1A). In keeping with our earlier studies (Khalilov
et al., 2003, 2005), KA generated an ictal-like event (ILE) with
large amplitude (1–2mV) and duration (1–2min) ictal discharges
(Figure 1A; see alsoKhalilov et al., 2003). These ILEs propagated to
the contralateral hippocampus where they generated similar activ-
ities including high frequency (40–120Hz) gamma oscillations
(GOs; Figures 1A,B). In earlier experiments we have demon-
strated that after circa 15 repeated unilateral KA applications,
the contralateral hippocampus generated spontaneous ILEs when
disconnected from the treated ipsilateral hippocampus (Khalilov
et al., 2003, 2005). We referred to this as a newly formed secondary
epileptogenic focus – or MF.
We have shown recently that early applications of (PB, 100 μM)
to the contralateral hippocampus reduced dramatically the sever-
ity of propagating seizures and prevented the formation of a
MF (Nardou et al., 2011). In contrast, in similar experiments,
DZP (2μM) augmented the severity of the propagating ILEs
(Figures 1C,C1,D,D1).
The frequency of oscillations is an important component of the
pathogenic actions of seizures. Indeed, in both human and exper-
imental animals, high frequency oscillations (HFOs; >60Hz)
constitute a signature of the severity of recurrent seizures (Bra-
gin et al., 1999; Khalilov et al., 2005; Le Van Quyen et al., 2006;
Jacobs et al., 2008). In keeping with this, in the same prepara-
tion, the occurrence of GOs in propagating seizures is essential
to induce the transformation of a naïve network to one that
generates ILEs spontaneously (Khalilov et al., 2005). Whereas
PB reduced the frequency of GOs and severity (power) of ILEs
(Nardou et al., 2011), DZP augmented the range of GOs frequen-
cies (Figures 1C1) and the power of ILEs (by 19.2± 3.9%, n = 7,
p< 0.05) in the contralateral hippocampus already with the ﬁrst
application (Figures 1D1). DZP in contrast to PB did not prevent
the formation of an epileptogenic MF (Figure 1E).
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FIGURE 1 | Diazepam (DZP) aggravates the propagating ictal-like events
(ILEs) and does not prevent the formation of a mirror focus by repeated
ILEs. (A,B)The scheme of the triple chamber preparation with the two intact
hippocampi and their connecting inter-hemispheric commissure in
independent chambers (left ). Field recordings were made in the two
hippocampi. (A) Kainate (KA) applied to one hippocampus (ipsilateral: ipsi-)
generated seizure activity referred to as ILE that propagated to the
contralateral hippocampus (contra-).The ILEs included high frequency gamma
oscillations (GOs, 40–120Hz) as shown in the time–frequency (TF) analysis
(A1). (B) Application of DZP to contralateral hippocampus (2μM, 15min)
before a second application of KA increased the ILE and GOs. TF analysis of
ILE recorded in contra- is shown in (B1). (C) Superimposed ILEs [from (A,B)]
recorded in contra- before (black) and after DZP application (red). DZP
increased the amplitude and duration of ILE. (C1) Power spectra
representation of ILEs recorded before (black) and after (red) DZP treatment
[from (C)] after band-pass (40–150Hz) ﬁltering. (D) Example of power spectra
of ILEs before and after DZP treatment [from (A,B)] used for calculation of
power of ILEs. (D1) Normalized average power histogram of contralateral ILEs
before and after DZP. Note that DZP application signiﬁcantly increased
average power of ILEs (by 19.2±3.9%, n =7 experiments, p<0.05). (E) After
15 transient applications of KA in ipsi- with continuous application of DZP in
contra-, disconnection of the two hippocampi by applications of TTX to the
commissural chamber revealed that contralateral hippocampus generated
spontaneous ILEs.
Therefore, PB and DZP exert opposite actions on sever-
ity of early ILEs in the intact hippocampus: PB reduces and
DZP aggravates the propagating ILEs from the onset of their
applications.
DIAZEPAM AGGRAVATES THE SEVERITY OF EPILEPTIFORM ACTIVITIES
IN THE ISOLATED MIRROR FOCUS
In earlier studies, we showed that once formed the MF gener-
ates spontaneous ILEs up to 1–2 days in an isolated hippocampus
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in vitro, and slices prepared from this hippocampus generate spon-
taneous and evoked interictal-like events (IILEs; Khalilov et al.,
2003, 2005;Nardou et al., 2009, 2011). Inwhole hippocampus after
the formation of MF, application of DZP signiﬁcantly increased
the severity of ILEs. The average power of spontaneous ILEs in
MF hippocampus after bath application of DZP increased by
80± 19.8% (n = 4, p< 0.001; Figure 2A). In slices prepared from
the hippocampus afterMF formation,DZP increased both the fre-
quency of IILEs and extracellular recorded spikes generated by the
MF neurons (Figure 2B). In similar experiments, PB also aggra-
vated the epileptiform activity generated by the MF by enhancing
the strong excitatory actions of GABA (Nardou et al., 2011).
Therefore, the difference between DZP and PB is valid for initial
propagating seizures but not for spontaneous seizures generatedby
an epileptogenic MF suggesting that the persistent accumulation
of [Cl−]i prevails in MF neurons rendering difﬁcult the actions of
GABA acting AEDs. Therefore, we next compared the actions of
DZP and PB on ongoing network activity in slices obtained from
control hippocampus.
DZP AUGMENTS ONGOING NEURONAL ACTIVITY AND FREQUENCY OF
GDPs
In control conditions, the physiological pattern of the immature
hippocampal network activity is characterized by spontaneous
network driven giant depolarizing potentials (GDPs; Ben-Ari et al.,
1989) that occur spontaneously and can be evoked by electri-
cal stimulation. GDPs are generated by the converging actions
of GABA and glutamatergic synapses (Ben Ari et al., 2007). We
tested the effects of DZP on the frequency of occurrence of extra-
cellular recorded GDPs and MUAs. As shown in Figure 3 DZP,
applied at a concentration of 2μM, increased the frequency of
GDPs by 215.1± 13.6% (p< 0.001, n = 14) and the frequency
of spikes by 170± 14.8% (p< 0.001, n = 14). In similar experi-
ments, bath application of PB substantially reduced the amplitude
of GDPs. PB reduced also the frequency of spontaneous spikes
generated in CA3 pyramidal neurons by∼50% (see Nardou et al.,
2011). An additional non-exclusive mechanism is that GDP fre-
quency being increased, there may also be a short-term depression
of GABAergic inputs that would be superimposed on the effect of
DZP.
To determine the actions of DZP on GABA signaling, we tested
the effects of DZP on responses generated by focal applications
of GABA. As shown in Figure 4A, GABA was focally applied
(100μM, 100ms) in the CA3c region while simultaneous CA3c
ﬁeld and whole cell recordings (from pyramidal neurons in CA3a
region) were performed. Focal GABA application generated GDPs
(Figure 4B). Application of DZP signiﬁcantly increased the ampli-
tude anddurationof whole cell recorded responses (Figures 4B–E)
accompanied by a 17.2± 2.7% (p< 0.05) as well as the area and
decay time constant of the currents (Figures 4C–E) increase in
the amplitude of extracellular recorded GDPs (not shown) and
with a strong increase in the number of GDPs-associated spikes
(98.1± 6.7%, p< 0.001, n = 5; Figure 4F). Similar focal appli-
cation of GABA generated 2–3 action potentials (spikes) in cell
attached recordings (see Nardou et al., 2011). In contrast to
DZP, bath applications of PB (100μM) signiﬁcantly reduced the
number of spikes (action potentials) from 2.7± 0.2 to 1.9± 0.2
(Nardou et al., 2011). Therefore, under control conditions PB
reduces ongoing neuronal activity whereas DZP augments it. The
observation that GABA acting PB reduces and DZP augments
ongoing activity raises the possibility of non-GABA mediated
actions of these AEDs. We therefore compared their effects on
glutamatergic signals that are instrumental in the generation of
early network activity.
PB BUT NOT DZP REDUCES AMPA/KAINATE RECEPTOR MEDIATED
FIELD POTENTIALS
To determine the effects of DZP and PB on glutamatergic activ-
ity, we ﬁrst studied their effects on ﬁeld potentials recorded in
control slices in the presence of bicuculline (10μM), CGP (2μM)
andAPV (40μM), respectively, to block GABA(A),GABA(B), and
NMDA receptors. In these conditions, all or none IILEs are gener-
ated spontaneously and by local electrical stimuli (Figure 5). IILEs
aremediated byAMPA/kainate receptors as theywere fully blocked
by the selective antagonist CNQX (10μM, n = 13; Figure 5C).
PB fully blocked the evoked and spontaneous IILEs (Figure 5A;
n = 7). The frequency histograms (Figure 5Ad) reﬂect the power-
ful blockade of spikes and IILEs by PB. As 10μm bicuculline do
not always fully block GABAergic signaling (Strata and Cherubini,
1994) we also repeated these experiments with 100μM picro-
toxin instead of bicuculline and observed similar actions of PB
(not shown, n = 3). In contrast, DZP (n = 6) failed to block or
reduce these ﬁeld potentials (Figure 5B). Thus, DZP did not
reduce the evoked or the spontaneous IILEs. Therefore, PB but
not DZP exerts a non-GABA mediated action on hippocampal
neurons.
PHENOBARBITAL BUT NOT DIAZEPAM REDUCES AMPA/KAINATE
RECEPTOR MEDIATED CURRENTS
To examine the possible effects of PB and DZP on AMPA/kainate
receptors, we next tested their effects on the currents evoked in
whole cell recordings by focal pressure applications of glutamate.
In the presence of NMDA and GABA receptor antagonists, focal
applications of glutamate (100μM, 100ms) from patch pipettes
generated large currents mediated by AMPA/kainate receptors as
they are blocked by CNQX (n = 9; Figure 6C). PB reduced signiﬁ-
cantly the amplitude of these currents (to 67.2± 8.1%, p< 0.001,
n = 4; Figure 6A). These effects fully recovered after wash out of
PB (Figure 6Ad). In contrast, DZP had no effects on these cur-
rents (mean amplitude in DZP was 100.3± 4.9% of the control
values, p> 0.05, n = 5; Figure 6B). Next, in similar experimental
conditions using fast agonist application techniques (Colquhoun
et al., 1992) glutamate (1mM, 2ms) was applied to the nucle-
ated patch clamp recorded CA3 pyramidal neurons. As shown
in Figure 7, PB signiﬁcantly reduced the amplitude of glutamate
induced currents (by 25.5± 0.5%, p< 0.001, n = 8). The decay
time constant of these currents was not changed in the presence
of PB (3.6± 0.5ms in control and 3.4± 0.4ms in the presence
of PB, respectively, p> 0.5). In similar experiments DZP had
no statistically signiﬁcant effects on glutamate induced currents
(mean current amplitude in DZP was 97.9± 3% of the control,
p> 0.3, n = 4, not shown). In addition, we tested the effect of
PB and DZP on NMDA receptor mediated currents. In the pres-
ence of AMPA/kainate and GABAreceptor antagonists focal puff
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FIGURE 2 | Diazepam aggravates the severity of epileptiform activities
in the isolated mirror focus. (Aa) Superimposed ILEs generated
spontaneously in the contralateral hippocampus after formation of a MF
before (black) and after (gray) DZP application. (Ab) Power spectra of
spontaneous ILEs before and after DZP treatment [from (Aa)]. (Ac) Average
power histogram of spontaneous ILEs before and after DZP. DZP application
signiﬁcantly increased power of ILEs (by 80±19.8%, n =4, p<0.001).
(Ba) Extracellular recording in slices obtained from contralateral hippocampus
after the formation of a MF. Slices generated spontaneous IILEs and
multi-unit activities (MUAs) continuously that were reversibly aggravated
by DZP (2μM). (Bb) Quantiﬁcation of IILEs from a single experiment
[from (Ba)]. (Bc) Average quantiﬁcation histogram of IILEs. (Bd)
Quantiﬁcation of spikes from single experiment [from (Ba)] and (Be) the
average quantiﬁcation histogram. Note that DZP increased the frequency of
IILEs (by 128.7±12.2%, n =6, p<0.001) and spikes (by 88.6±16.2%, n =6,
p<0.001).
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FIGURE 3 | Diazepam increases ongoing neuronal activity and network
driven GDPs. (A) Extracellular recording of the Giant Depolarizing Potentials
(GDPs) and multi-unit activities (MUAs) in control slices to record network
driven events and individual neuronal spikes, respectively. Non-ﬁltered faster
display traces are depicted below to show spikes. Note the increase of
frequency of GDPs (B) and spikes (D) by DZP: (B–D) quantiﬁcation of
recorded GDPs and spikes from (A), Bin=20 s. (C–E) Quantiﬁcation of mean
frequency of GDPs and spikes. DZP enhanced the frequency of GDPs (C) by
215.1±13.6 (p<0.001, n =14) and spikes (E) by 170±14.8% (p<0.001,
n =14).
applications of glutamate (100μM,100ms) generated (at+40mV
holding potential) large amplitude outward currents. These cur-
rents are mediated by NMDA receptors as they were blocked by
the NMDA receptor antagonist APV (40μM, n = 11, not shown).
As shown in Figure 8, neither PB nor DZP altered these currents.
Therefore,PB selectively reducesAMPA/kainate receptormediated
currents.
PRE- AND POSTSYNAPTIC ACTIONS OF PB ON AMPA RECEPTOR
MEDIATED EXCITATORY POSTSYNAPTIC SYNAPTIC CURRENTS
To examine the pre- and postsynaptic mechanisms underlying
the actions of PB, we used whole cell recordings to determined
the effects of PB on the monosynaptic AMPA receptor-dependent
EPSCs evoked by local electrical stimulations.We applied minimal
electrical stimuli to generate all-or-none monosynaptic EPSCs
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FIGURE 4 | DZP enhances GABA excitation in naive
neurons. (A) Experimental design. Simultaneous whole cell patch
clamp recordings of a CA3a pyramidal neuron and ﬁeld recordings
in the CA3c pyramidal layer were made in control slices and GABA
(100μM) was focally applied (100ms) by puff in the CA3c part of the
pyramidal layer. (B) GABA puff generated a ﬁeld and whole cell recorded
GDPs (Ba) that was strongly augmented by DZP (Bb). The responses
returned to control values after wash out of DZP (Bc). (C–E) Quantiﬁcation
of the effects of DZP on whole cell recorded postsynaptic currents: the
amplitudes of the currents, the decay time and the area of whole
cell recorded responses were signiﬁcantly augmented by DZP. (F)
Quantiﬁcation histogram of mean number of spikes associated with puff
GABA generated GDPs (a time window of 1 s from the GDP onset from
GABA puff was analyzed).
(see Kullmann, 1994; Stevens and Wang, 1994). In the presence
of NMDA and GABA receptor antagonists, an electrical stimula-
tion evoked an all-or-none evokedAMPA receptormediated EPSC
(Figure 9). PB increased the number of failures of evoked AMPA
receptor-dependent EPSCs (by 92.1± 30.1%, p< 0.001, n = 8;
Figure 9Ae). In parallel experiments, miniature AMPA EPSCs
(mEPSCs) were recorded in the presence of TTX to block ongo-
ing network activity. PB reduced (Figure 9B) the amplitude (by
28.9%, from 25.9± 1.4 to 20.1± 0.9 pA, p< 0.01, n = 8 slices),
and frequency of the mEPSCs (by 38.6± 8.0%, p< 0.01, n = 8
slices, not shown, 5min recordings analyzed before, during and
after wash out of PB). Therefore, PB exerts a selective action
on ongoing and evoked glutamatergic exogenous and synap-
tic currents that is mediated by AMPA/kainate but not NMDA
receptors.
PRESERVATION OF THE AMPA/KAINATE RECEPTOR INHIBITORY
ACTIONS OF PB IN MIRROR FOCUS NEURONS
To examine whether PB reduces theAMPA/kainate receptor medi-
ated currents in “epileptic” tissue we used slices obtained from
contralateral hippocampus after the formation of MF. As shown
in Figure 10Aa,b, in control conditions these MF slices generate
spontaneous IILEs (see also Khalilov et al., 2003, 2005; Nardou
et al., 2009, 2011). After blockade of GABA and NMDA recep-
tors, the IILEs transformed into AMPA/kainate receptor mediated
ILEs (Figure 10Ac) as they were reversibly blocked by CNQX
(10μM,not shown). Addition of PB (100μM) in these conditions
signiﬁcantly reduced the amplitude (by 22.7± 4.2% to controls,
n = 5, p< 0.001, not shown) and frequency of ILEs: PB increased
the mean interval between ictal-like events by 318.1 ± 66.5%
(p< 0.001, n = 5 slices; Figure 10C). PB signiﬁcantly decreased
also the power of AMPA/kainate receptor-dependent ictal-like
events Figure 10B,C (by 26.9± 7.2%, n = 5, p< 0.001). There-
fore, the inhibitory actions of PB on AMPA/kainate receptors are
preserved in MF “epileptic” neurons.
DISCUSSION
Our results ﬁrst suggest that PB has a higher efﬁcacy than DZP
to reduce early seizures thanks to its dual action on GABA and
AMPA/kainate receptor mediated currents. DZP aggravates inau-
gurating propagated seizures most likely because at that develop-
mental stage many naïve neurons have elevated [Cl−]i. (Nardou
et al., 2009). However, in ongoing epileptogenic mirror foci, where
GABA strongly excites neurons, PB like DZP aggravates seizures
in spite of the reduction of glutamatergic currents that it pro-
duces. Therefore, the efﬁcacy of DZP like PB in reducing seizures
is conditioned by the actions of GABA. When these are strongly
excitatory due to a strong increase of [Cl−]i, the reduction of
the excitation by glutamate will not sufﬁce to block seizures. Our
observations of direct actions of PB on AMPA/kainate but not
NMDA currents suggest a speciﬁc not yet identiﬁed recognition
site. In spite of the inherent limitations of in vitro experimental
models, the present results suggest that for the treatment of early
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FIGURE 5 | Phenobarbital but not diazepam blocks AMPA/kainate
mediated inter ictal-like events (IILEs). (Aa,Ba) Extracellular recordings of
spontaneous and evoked (electrical stimulation every 30 s) IILEs generated in
control slices in the presence of GABA receptors antagonists – bicuculline
(10μM), CGP (2μM), – and NMDA receptors antagonist – APV (40μM).
Non-ﬁltered faster display traces of evoked (Ab,Bb,Cb) and spontaneous
(Ac,Bc,Cc) IILEs. Generation of IILEs in these conditions is mediated by
AMPA/kainate receptors as they were reversibly blocked by CNQX (C). Note
that PB but not DZP completely blocked IILEs and reduced the frequency of
spikes (Ad,Bd).
FIGURE 6 | Phenobarbital but not diazepam reduces AMPA/kainate
mediated currents. (A–C)Whole cell patch clamp recordings of currents
induced by focal application of glutamate (100μM, 100ms) in the presence
APV (40μM). (Ae–Ce) Histograms of normalized averaged amplitudes of
glutamate induced currents showing the effects of PB (Ae), DZP (Be), and
CNQX (Ce). Note that phenobarbital but not diazepam signiﬁcantly reduced
the amplitude AMPA/kainate receptor mediated postsynaptic currents
(67.2±8.1%, p<0.001, n =4). NS, not statistically signiﬁcant.
neonatal seizures PB may be more efﬁcient than DZP. Further-
more, agents that exert a dual action on GABA and AMPA/kainate
receptors may offer an interesting novel therapeutic perspective to
treat neonatal seizures, provided that they are used at the ear-
liest stages as the GABA polarity shift remains a fundamental
point.
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FIGURE 7 | Phenobarbital reduces AMPA receptor mediated currents in
nucleated patches. (A) Currents evoked in nucleated patches from CA3
pyramidal neurons from control slices. L-Glutamate (Glu, 1mM) was
applied in 2ms pulses at a holding potential of −60mV. Each trace is the
average of 4–8 sweeps. Note that PB [(A) red trace] reduced the amplitude
of AMPA/kainate mediated currents. (B) PB signiﬁcantly reduced (by
25.5±0.5%, p<0.001, n =8) the averaged amplitude of AMPA/kainate
receptor mediated currents recorded in nucleated patches.
DZP AUGMENTS AND PB REDUCES ONGOING NEURONAL ACTIVITY
AND EARLY SEIZURES
The effects of PB and DZP on GABAergic signals have been exten-
sively investigated and will not be reviewed here (Barker and
Gainer, 1973; Barker and Ransom, 1978; Barker and McBurney,
1979;Macdonald andBarker, 1979;Macdonald andMcLean,1982;
Macdonald et al., 1986; Cheng et al., 2002; Soderpalm, 2002;
Rogawski and Loscher, 2004; Czapinski et al., 2005; Macdonald
and Rogawski, 2007; Stefan and Feuerstein, 2007). In short, both
act directly on postsynaptic GABA receptors leading to a more
powerful inhibition of target neurons. Classically, DZP potenti-
ates GABA(A) receptor function by increasing channel opening
frequency, whereas barbiturates increase channel open duration
(Feng et al., 2004; Hanson and Czajkowski, 2008; Reid et al., 2009)
by acting on different target sites on the GABA receptor chan-
nel complex (Feng et al., 2004; Hanson and Czajkowski, 2008;
Mercado and Czajkowski, 2008). There are however several com-
plicating factors. Benzodiazepine actions are highly dependent on
the levels of GABA present (Mercik et al., 2007; Mozrzymas et al.,
2007), the binding/unbinding of DZP fromGABAA is highly com-
plex (Jones-Davis et al., 2005; Bianchi et al., 2007a,b) and GABA
receptor subunits and diazepam binding sites are internalized after
seizures (Goodkin et al., 2008;Goodkin andKapur, 2009). System-
atic experimental comparisons of the actions of various GABA
acting AEDs on neonatal network driven events have been sel-
dom investigated. In the immature rat hippocampus, diazepam
increases frequency yet slows downpropagationof GDPs (Khalilov
et al., 1999; Valeeva et al., 2010) whereas PB does not affect GDPs
frequency (Dzhala et al., 2008) and reduces GDPs amplitude (Nar-
dou et al., 2011). These observations are not readily compatible
with an additional presynaptic action of PBon the release of GABA
although this cannot be excluded at present. Collectively these
observations are important considering the profound impact of
ongoing network activity on transmitter release and the operation
of developing cell assemblies. Thus,Cherubini and colleagues have
elegantly shown that GDPs modulate GABA release via BDNF and
othermessengers (Sivakumaran et al., 2009). Since PB reduced and
DZP augmented GDPs and early seizures we investigated the pos-
sibility that target sites other than GABA signaling could underline
these differences.
PB REDUCED AMPA/KAINATE RECEPTOR MEDIATED CURRENTS
Several studies have shown earlier that PB (and pentobarbital)
reduced glutamatergic AMPA/kainate receptor mediated currents
including: (i) a subunit selective action on kainate-induced cur-
rents in Xenopus oocytes expressing different GluR subunits
(DildyMayﬁeld et al., 1996; Minami et al., 1998); (ii) a reduction
of glutamate currents in spinal cord neurons (Barker and Gainer,
1973;MacDonald andBarker, 1978b; Taverna et al., 1994; Joo et al.,
1999). PB – like DZP (Rovira and Ben-Ari, 1994) – also reduced
calcium currents (Werz and Macdonald, 1985). In contrast, zolpi-
dem had no effects in young animals but decreased calcium and
barium spikes in adults whereas midazolam increased barium
spikes in both young and adult animals (Rovira and Ben-Ari,
1994). The contributions of these non-GABA mediated signal-
ing remained however controversial (Kamiya et al., 1999; also see
Barker and Gainer, 1973; Barker and Ransom, 1978).
Present results provide direct evidence that PB but not DZP
tested in the same preparation exerts a strong modulation of glu-
tamatergic receptors and synaptic glutamatergic currents. Thus,
PB strongly reduced the amplitude and frequency of miniature
AMPA/kainate receptormediated EPSCs generated in the presence
of TTX, indicating a direct pre- andpostsynaptic action of PB. This
was conﬁrmed directly by showing that PB increased the frequency
of failures evoked in an all-or-none manner by minimal electrical
stimuli, and reduced the amplitude of the responses evoked by
focal applications of glutamate in the presence of the same cock-
tail of receptor antagonists and directly the amplitude but not the
kinetic of AMPA/kainate currents in nucleated patches. The mol-
ecular targets of these actions have not been determined and are
outside the scope of the present study. Interestingly, presynaptic
activation of kainate receptors inCA3 neurons alters GABA release
raising the possibility of an indirect modulation of GABAergic
signals by PB (Caiati et al., 2010).
The increase of thenumberof failures byPBaswell as the reduc-
tion of the frequency of miniature EPSCs suggests also presynaptic
effects in addition to the postsynaptic ones. Such effects have long
been observed in a variety of preparations. Thus, PB decrease
mono- and polysynaptic reﬂexes in the spinal cord (Nicholson
et al., 1988) and the anesthetic actions of barbiturates have been
ascribed in part by a reduction of presynaptic calcium entry and
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FIGURE 8 | Phenobarbital does not reduce the NMDA receptor mediated
currents. (A,Da,b)Whole cell patch clamp recordings (V clamp =+40mV) of
currents induced by focal application of glutamate (100μM, 100ms, arrows)
in the presence of bicuculline (10μM), CGP (2μM), and CNQX (20μM;
antagonist of AMPA/kainate receptors). Averaged NMDA receptor mediated
currents before (Aa), in the presence (Ab), and after wash out of PB (Ac)
recorded from the same pyramidal cell. (Ba) Histogram of averaged (n =11)
amplitudes of NMDA receptor mediated currents. (Bb) Histogram of averaged
amplitudes normalized to control. Averaged NMDA receptor mediated
currents before (Ca) and in the presence of DZP (Cb). (Cc) Histogram of
averaged (n =5) current amplitudes normalized to control. NS, not statistically
signiﬁcant.
consequent reduction of neurotransmitter release in mouse spinal
cord neurons (Heyer and Macdonald, 1982). Different concentra-
tion dependent actions of the pre- and postsynaptic actions of PB
and barbiturates have also been reported in the frog neuromus-
cular junction (Proctor and Weakly, 1976). Clearly, these effects
may also contribute to the anticonvulsive actions of PB but the
importance of their contribution remains to be determined.
DZP ENHANCES ONGOING ACTIVITY AND AGGRAVATES SEIZURES
The effects of DZP on GDPs are quite striking and to some extent
unexpected. They suggest that by enhancing the excitatory actions
of GABA on immature neurons, agents that exert solely this action
will produce unwarranted effects. The underlyingmechanisms are
not clear at present; they may include speciﬁc effects on interneu-
rons that orchestrate GDPs (Bonifazi et al., 2009) and/or enhance
possible depolarizing tonic GABA currents in pyramidal cells that
is important at that early stage and provides a large current (Ge
et al., 2006; Sebe et al., 2010). Benzodiazepines are extensively used
to block status epilepticus. In adult animalmodels diazepam is sys-
tematically injected after administrations of kainate or pilocarpine
to prevent animal death consequently to the recurrent seizures
(Ben-Ari et al., 1978; Ben-Ari, 1985; Cavalheiro et al., 1996). In
contrast, DZP – like PB – is not efﬁcient to block seizures after
recurrent seizures have taken place (see below). Here,we show that
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FIGURE 9 | Pre- and postsynaptic actions of PB onAMPA/kainate
receptor mediated excitatory postsynaptic synaptic currents (EPSCc). (A)
In the presence of APV (40μM) and bicuculline (10μM), single ﬁbers were
electrically stimulated to evoke a mono synaptic AMPA receptor mediated
EPSCs. The stimulation was adjusted to induce ∼20–50% failures [shown as
red trace in (Aa2)]. (Aa–c) Single experiment obtained with repeated stimuli
(30 stimuli every 10 s). (Aa) Control, (Ab) PB strongly enhanced the number
of failures and reduced the average amplitude of EPSCs [see also (Ae)], (Ac)
wash out of PB. (Ad) Superimposed averaged responses (the failures were
discarded) from (Aa–c) to illustrate the effects of PB. Note the reduction of
the averaged amplitude of EPSCs in the presence of PB (red trace). (Ae)
Quantiﬁcation of the mean number of normalized failures. Failure rate
presented as “percentage of failure” (number of failure/total number of
stimulation). Note the highly signiﬁcant increase of the number of failures in
the presence of PB (p<0.001, n =4 experiments). (B) PB reduces the
amplitude of miniature AMPA receptor mediated EPSCs (mEPSCs). APV
(40μM) and bicuculline (10μM) were applied throughout the recordings as
well as TTX (1μM) to generate mEPSCs. (Ba–c) Single traces to illustrate the
actions of PB on AMPA receptor mediated mEPSCs. Note that PB (middle
trace) reduced the amplitude of the minis. (Bd) Superimposed averaged
traces of single mEPSCs to illustrate the effects of PB [from (Ba–c)]. Note the
reduction of the mEPSCs amplitude (red trace). (Be) Quantiﬁcation of the
effects of PB. Note that PB reduced signiﬁcantly (by 28.9%; from 25.9±1.4
to 20.1±0.9 pA, p<0.01, n =5 cells from different slices) the averaged
amplitude of mEPSCs. PB also reduced the frequency of mini EPSCs (see
text). (C) Cumulative probability distributions of mEPSCs amplitude in the
presence of PB (red curve) demonstrate a leftward shift as compared with
control and wash out. (D) Cumulative probability distribution of mEPSCs
inter-event intervals in the presence of PB demonstrates a rightward shift as
compared with control and wash out.
DZP aggravates seizures from their onset in neonatal hippocampi.
The effects of DZP were highly reproducible, associated with a
signiﬁcant increase of the HFOs and consequently with the forma-
tion by seizures of an epileptogenic MF. Indeed, as shown earlier,
there is a direct link between HFOs and the formation by seizures
of an independent MF capable of generating seizures (Khalilov
et al., 2005). These actions are also in keeping with our earlier
report showing that functional GABAergic receptors are essential
for the formation by seizures of aMF, since applications of aGABA
receptor antagonist generated epileptiform events that however
were neither associated with HFOs nor with the formation of an
epileptogenic MF (Khalilov et al., 2005).
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FIGURE 10 | Phenobarbital reduces AMPA/kainate receptors
field potentials in mirror focus neurons. (A) Extracellular ﬁeld
recording of spontaneous epileptiform activities in slices obtained
from contralateral hippocampus after mirror focus formation. Recordings
were performed in the presence of GABA(A) and GABA(C) receptors
antagonist PTX (100μM), GABA(B) receptor antagonist CGP (2μM), and
NMDA receptor antagonist APV (40μM). (Ab) Example of epileptiform
activities recorded in an “epileptic” slice from mirror focus before application
of antagonists. (Ac–e) Examples of ILEs in the presence of GABA and
NMDA receptors antagonists: before application (Ac), in the
presence (Ad), and after PB wash out (Ae). Note the signiﬁcant
decrease of amplitude and frequency of ictal-like events. Mean interval
between ictal-like events (double arrows) signiﬁcantly increased (by
318.1±66.5%, not shown). (B) Power spectrum [from (Ac–d)] showing the
decrease of amplitude and frequency by PB. (C) Average power histogram of
spontaneous ictal-like events before and after application of PB. PB
signiﬁcantly decreased the power of epileptiform events (by 26.9±7.2%,
n =5, p<0.001).
RECURRENT SEIZURES ABOLISH THE ADVANTAGES OF PB OVER DZP:
CRUCIAL ROLE OF INTRACELLULAR CHLORIDE LEVELS
There is now direct evidence from humans and experimen-
tal animals that recurrent seizures produce an accumulation
of [Cl−]i associated with a shift of the actions of GABA
from inhibitory to excitatory (Cohen et al., 2002; Khalilov
et al., 2003, 2005; Payne et al., 2003; Blaesse et al., 2009; Nar-
dou et al., 2011). The underlying mechanisms are now bet-
ter understood. It has been recently shown that GABA excites
epileptic neurons because of high intracellular chloride medi-
ated by a combined action of the NKCC1 chloride importer
(Dzhala et al., 2010) and a down regulation of the chloride
exporter KCC2 (Lee et al., 2010; Nardou et al., 2011), lead-
ing to strong excitatory actions of GABA that are exacerbated
by PB. Therefore, although PB is more efﬁcient than DZP to
block early neonatal seizures, by shifting the actions of GABA
to strongly excitatory, recurrent seizures abolish this advantage
stressing the importance of an early aggressive treatment of
seizures to avoid the loss of KCC2 activity and preserve the efﬁcient
actions of PB.
CLINICAL IMPLICATIONS
There are many obvious limitations to the in vitro preparations
that restrict the relevance of these observations to a clinical
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situation including the lack of major cerebral connections, sys-
temic events (vascular, hormonal, etc.) and the different species.
Yet, the in vitro MF model used here has several advantages over
conventional slices in that it enables to determine the activity
of neuronal ensembles in relatively preserved conditions and to
compare the actions of AEDs on acute and more chronic propa-
gating seizures in neurons that have never been in contact with a
convulsive agent. Our results suggest important advantages of PB
over DZP since the former exerts a dual action and is not exclu-
sively restricted to GABA signal. Although the magnitude of these
effects is relatively small, they are stable and observed in naïve
and “epileptic” neurons suggesting that AEDs with a dual action
may be advantageous over agents that exert solely a pro-GABA
action. This is particularly important in view of the vulnera-
bility of intracellular chloride shifts with recurrent seizures that
strongly limit the efﬁcacy of GABA acting AEDs. There is now lit-
tle doubt that in humans, like in experimental animals, GABA
may excite epileptic neurons and this will seriously aggravate
the situation. The history of seizures prior to AEDs is clearly
an important element to take in consideration in order to pre-
serve as much as possible the capacity of neurons to control their
[Cl−]i.
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